Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Catalyst OrthoScience Names Mark Quick as CFO - Orthopedic Design & Technology

What are you searching for?

Sign in
OEM News, People News

Catalyst OrthoScience Names Mark Quick as CFO

Quick was most recently at Orthofix, where he served in financial leadership and business development roles.

Author Image

By: Sam Brusco

Associate Editor

Catalyst OrthoScience has named seasoned medical device leader Mark Quick as its new chief financial officer (CFO) effective immediately.
 
With almost two decades of medical device experience, Quick was most recently at Orthofix where he served in financial leadership and business development roles of increasing responsibility. Before Orthofix, he was a sell-side equity research analyst covering the medical device industry at Canaccord Genuity.
 
“I am thrilled to join Carl and the rest of the talented Catalyst team in their commitment, dedication, and focus to providing differentiated solutions to shoulder surgeons and patients,” Quick told the press. “With its growing product portfolio, Catalyst is positioned to accelerate expansion of its distribution channel leading to broad adoption in the high-growth $1.5 billion U.S. shoulder replacement market.”
 
Catalyst recently earned U.S. Food and Drug Administration (FDA) 510(k) clearance for its fully convertible stemmed total shoulder arthroplasty system with ellipsoid anatomic head. It’s the market’s first such device and expands Catalyst’s portfolio to offer stemless, stemmed, and convertible shoulder replacement options.
 
“Mark brings a wealth of expertise in the medical device market to our team, and we are excited to leverage his decades of experience as we continue to grow,” said Carl O’Connell, CEO and president of Catalyst. “Our purposely designed approach to shoulder replacement surgery is focused squarely on solutions that better match the patient’s own anatomy, reduce complications and support the needs of surgeons for precision, accuracy and repeatability.”

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Add Orthopedic Design & Technology as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters